(Q48353734)

10 February 2018

title

Tumor-specific killer cells in paraneoplastic cerebellar degeneration (English)

1 reference

10 February 2018

author name string

Albert ML

1 reference

10 February 2018

Darnell JC

1 reference

10 February 2018

Bender A

1 reference

10 February 2018

Francisco LM

1 reference

10 February 2018

Bhardwaj N

1 reference

10 February 2018

Darnell RB

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

10 February 2018

published in

Nature Medicine

1 reference

10 February 2018

volume

1 reference

10 February 2018

issue

1 reference

10 February 2018

page(s)

1321-1324

1 reference

10 February 2018

Dendritic cells as adjuvants for immune-mediated resistance to tumors

cites work

1 reference

7 January 2021

Cancer Tumor antigens

1 reference

7 January 2021

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain

1 reference

7 January 2021

Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes

1 reference

7 January 2021

Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration

1 reference

7 January 2021

Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration

1 reference

7 January 2021

Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration

1 reference

7 January 2021

A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues

1 reference

7 January 2021

Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients

1 reference

7 January 2021

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

1 reference

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

7 January 2021

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

1 reference

7 January 2021

Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities

1 reference

7 January 2021

Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies

1 reference

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

7 January 2021

Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer

1 reference

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

7 January 2021

Regulation of class I MHC gene expression in the developing and mature CNS by neural activity

1 reference

7 January 2021

Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells

1 reference

7 January 2021

HLA-A2 subtypes are functionally distinct in peptide binding and presentation

1 reference

7 January 2021

Identifiers

DOI

10.1038/3315

1 reference

10 February 2018

1 reference

10 February 2018